ACTRN12613000487718进行中（未招募）4 期
High Dose Melphalan: A pilot study to evaluate pharmacokinetic-based dose determination in patients with multiple myeloma scheduled to undergo autologous stem cell transplantation
The Children's Hospital at Westmead0 个研究点目标入组 30 人开始时间: 2013年5月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients of any age scheduled to receive single agent high dose melphalan and autologous stem cell rescue for multiple myeloma.
- •2. Written informed consent
排除标准
- •Those for whom written informed consent cannot be obtained.
研究者
相似试验
尚未招募
不适用
A study to evaluate the efficacy of Phalatrikadi Kashaya and Daruharidraghana Vati in Non- Alcoholic Fatty Liver DiseaseCTRI/2021/05/033410RGGPG Ayurvedic College and Hospital
进行中（未招募）
1 期
A study of the safety and effects of one or more doses of HSP-130 injected under the skin in patients with breast cancer that has not spread to distant sites in the bodyEUCTR2015-002057-35-ESHospira, Inc.48
进行中（未招募）
1 期
A study of the safety and effects of one or more doses of HSP-130 injected under the skin in patients with breast cancer that has not spread to distant sites in the bodyEUCTR2015-002057-35-HUHospira, Inc.48
尚未招募
Unknown
Effect of Phala Ghrita and Panchvalkaladi Kwath Yoni Prakshlana on VulvovagnitisCTRI/2023/08/056850Madan Mohan Malviya Government Ayurved College Udaipur
进行中（未招募）
1 期
A PHASE II PROSPECTIVE STUDY OF HIGH-DOSE myeloablative therapy, WITH STEM CELL DEVICES SUPPORT IN ELDERLY PATIENTS (from 65 to 76 years) with relapsed aggressive non-Hodgkin lymphoma OR RESISTANT TO first line THERAPY.on Hodgkin LymphomaMedDRA version: 16.0Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-003256-20-ITFondazione Italiana Linfomi115